There was a notable decrease in common ophthalmic procedures among Medicare beneficiaries during the first year of the COVID-19 pandemic, according to a study published Feb. 6 in JAMA Ophthalmology.

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

SmartAsset ranked 810 U.S. counties based on the rate of people under age 65 who were insured in 2024, examining changes in ...